Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine for pediatric ER procedural sedation
2024-518816-38-00Phase 4Authorised
- Sponsor
- Oulu University Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anxiety disorder comparing Intranasal dexmedetomidine with Intranasal placebo (2 arms). Primary endpoint: Success of the procedure at the first attempt. Planned start Nov 2024; status: authorised.
02
Drugs
dexmedetomidine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on 2024-518816-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518816-38-00.